Clinuvel Pharmaceuticals
CUV.AX
#7382
Rank
C$0.45 B
Marketcap
$9.13
Share price
-3.74%
Change (1 day)
-35.98%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2024: C$48.28 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are C$59.01 Million. In 2024 the company made an earning of C$48.28 Million, an increase over its 2023 earnings that were of C$42.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024C$48.28 M12.42%
2023C$42.94 M27.77%
2022C$33.61 M22.23%
2021C$27.49 M114.01%
2020C$12.84 M-29.03%
2019C$18.1 M32.76%
2018C$13.63 M75.24%
2017C$7.78 M-332.09%
2016-C$3.36 Million-70.52%
2015-C$11.38 Million53.56%
2014-C$7.41 Million-16.31%
2013-C$8.86 Million-37.85%
2012-C$14.24 Million-18%
2011-C$17.37 Million25.86%
2010-C$13.8 Million-21.79%
2009-C$17.65 Million-11.73%
2008-C$19.99 Million80.71%
2007-C$11.06 Million-2.86%
2006-C$11.39 Million-4.95%
2005-C$11.98 Million60.55%
2004-C$7.47 Million97.37%
2003-C$3.79 Million50.62%
2002-C$2.51 Million121.22%
2001-C$1.14 Million254.48%
2000-C$0.33 Million